Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2020

01-11-2020 | Acute Liver Failure | DDS–SIRC COOPERATIVE CONFERENCES

Casting a Wider NET: An Unusual Cause of Acute Liver Failure in a Pregnant Patient

Authors: Jasleen Grewal, Jihane Benhammou, Priyal V. Patel, Sammy Saab, Gina Choi

Published in: Digestive Diseases and Sciences | Issue 11/2020

Login to get access

Abstract

We present a case patient in her second trimester of pregnancy who developed acute liver failure from metastatic neuroendocrine tumor (NET). Although she underwent prompt induction of a non-viable fetus due to initial concerns of hemolysis, elevated liver enzymes, and low platelet count syndrome, her liver function continued to deteriorate postpartum. She was subsequently transferred to our institution in order to undergo further evaluation that included a transjugular liver biopsy and subsequent diagnosis of high-grade NET. She was given salvage carboplatin-based chemotherapy, as she was not a liver transplant candidate. Unfortunately, the patient expired from cardiovascular collapse as a component of multiorgan failure.
Literature
1.
go back to reference Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet. 2010;375:594–605.CrossRef Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet. 2010;375:594–605.CrossRef
2.
go back to reference Barbier L, Neuzillet C, Dokmak S, et al. Liver transplantation for metastatic neuroendocrine tumor. Hepat Oncol. 2014;1:409–421.CrossRef Barbier L, Neuzillet C, Dokmak S, et al. Liver transplantation for metastatic neuroendocrine tumor. Hepat Oncol. 2014;1:409–421.CrossRef
3.
go back to reference Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326–1331.CrossRef Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326–1331.CrossRef
4.
go back to reference Demir SC, Evruke C, Ozgunen FT, et al. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J. 2006;27:1015–1018.PubMed Demir SC, Evruke C, Ozgunen FT, et al. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J. 2006;27:1015–1018.PubMed
5.
go back to reference European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–1081.CrossRef European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–1081.CrossRef
6.
go back to reference Lee W, Larson A, Straviz T. AASLD position paper: the management of acute liver failure: update 2011. Hepatology. 2011;55:1–22.CrossRef Lee W, Larson A, Straviz T. AASLD position paper: the management of acute liver failure: update 2011. Hepatology. 2011;55:1–22.CrossRef
7.
go back to reference Le Treut Y, Gregoire E, Klempnauer J, et al. Liver transplantation for neuroendocrine tumors in Europe—results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013;257:807–815.CrossRef Le Treut Y, Gregoire E, Klempnauer J, et al. Liver transplantation for neuroendocrine tumors in Europe—results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013;257:807–815.CrossRef
8.
go back to reference Nobel Y, Goldberg D. Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes. Transplantation. 2015;99:2341–2346.CrossRef Nobel Y, Goldberg D. Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes. Transplantation. 2015;99:2341–2346.CrossRef
9.
go back to reference Colquhoun S. Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options. Liver Res. 2018;2:92–99.CrossRef Colquhoun S. Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options. Liver Res. 2018;2:92–99.CrossRef
10.
go back to reference Yao J, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072.CrossRef Yao J, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072.CrossRef
Metadata
Title
Casting a Wider NET: An Unusual Cause of Acute Liver Failure in a Pregnant Patient
Authors
Jasleen Grewal
Jihane Benhammou
Priyal V. Patel
Sammy Saab
Gina Choi
Publication date
01-11-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06469-y

Other articles of this Issue 11/2020

Digestive Diseases and Sciences 11/2020 Go to the issue

Stanford Multidisciplinary Seminars

Negotiating Dire Straits with a BougieCap

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.